PHR insider sale notice: 2,059 vested shares to be sold via Fidelity

Rhea-AI Filing Summary

Form 144 filed for Phreesia, Inc. (PHR) shows a proposed sale of 2,059 common shares through Fidelity Brokerage Services with an aggregate market value of $48,386.50 and an approximate sale date of 09/17/2025. The shares were acquired by restricted stock vesting on 09/11/2025 and were issued as compensation. The filing reports total outstanding shares of 59,914,473. The filer also disclosed sales by Alison C. Hoffman within the past three months: 1,245 shares on 07/17/2025 for $33,472.82 and 3,133 shares on 09/16/2025 for $72,950.03. The notice includes the standard attestation that the seller is unaware of undisclosed material adverse information.

Insights

Financial Analyst

TL;DR: Insider proposes to sell a small block of vested shares; economic impact on outstanding float is negligible.

The filing documents a proposed sale of 2,059 shares valued at $48,386.50 against 59,914,473 shares outstanding, representing a de minimis fraction of the float. The shares were acquired via restricted stock vesting on 09/11/2025 and classified as compensation, indicating these are insider-originated equity awards being monetized. Prior transactions by the same individual show sales totaling 4,378 shares in the past three months for gross proceeds of $106,422.85. For investors, these transactions are routine insider liquidity events rather than a substantive change to capital structure or operational outlook.

Corporate Governance Expert

TL;DR: The filing reflects routine executive share vesting and subsequent dispositions with required attestations present.

The notice states the securities were acquired through restricted stock vesting and will be sold through a broker (Fidelity). The filer executed the standard attestation regarding no undisclosed material adverse information. Recent disposals by Alison C. Hoffman are transparently disclosed with dates and proceeds, satisfying Rule 144 reporting requirements. No indications of trading-plan dates or Rule 10b5-1 adoption are provided in the remarks section, so the sales appear to be standard post-vesting transactions reported under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2059	48386.50	59914473	09/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2025	Restricted Stock Vesting	Issuer			2059	09/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Alison C. Hoffman 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	1245	33472.82
Alison C. Hoffman 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	09/16/2025	3133	72950.03

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Phreesia (PHR) Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 2,059 common shares through Fidelity with an aggregate market value of $48,386.50 and an approximate sale date of 09/17/2025.

How were the shares being sold by the filer acquired?

The shares were acquired on 09/11/2025 via restricted stock vesting and the consideration is listed as compensation.

How many Phreesia shares were outstanding according to the filing?

59,914,473 shares outstanding is reported in the filing.

Did the filer or related person sell Phreesia shares recently?

Yes. Alison C. Hoffman sold 1,245 shares on 07/17/2025 for $33,472.82 and 3,133 shares on 09/16/2025 for $72,950.03.

Through which broker will the proposed sale be executed?

Fidelity Brokerage Services LLC (address listed in the filing) is named as the broker for the proposed sale.